Basic Information
Ziylo is a diabetes drug research and development company. Currently, Ziylo has developed biomimetic glucose-binding molecules (GBM) for continuous glucose monitors (CGM) and glucose-responsive insulin (GRI).
Enterprise Profile
Industrial Sector
Technology
Concept